U.S. equities were higher at the close on Wednesday, as gains in the Utilities, Financials and Basic Materials sectors ...

At the close in NYSE, the Dow Jones Industrial Average gained 0.79% to hit a new all time high, while the S&P 500 index gained 0.47%, and the NASDAQ Composite index added 0.28%.

In order to multiply the amount of plants in your garden, understanding what rooting hormones are and the types available are ...

At Morningstar, we think that the best dividend stocks aren’t simply the highest-yielding dividend stocks. We suggest that ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat ...

Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a ...

Merck (MRK) says it Capvaxive vaccine showed positive immune responses in a Phase 3 trial for adults at risk for pneumonia.

Former Merck CEO Ken Frazier and former American Express CEO Ken Chenault have warned companies pulling back from diversity, ...

Nodenza Venture Partners launchedFocus on international early-stage and pre-commercial biotech & medtech opportunitiesNew York, October 16, ...

Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system (CNS) conditions, ...

Nodenza Venture Partners launched - focus on international early-stage and pre-commercial ...

Globally recognised as a first-line standard of care, the public funding of ERBITUX® (cetuximab) [1] marks an important development for people living with left-sided RAS wild-type and BRAF wild-type ...